Vizora日本語

Kyowa KirinKyowa Kirin Co.,Ltd.4151東証プライム医薬品FY ending Dec 2025, consolidated, IFRS

Kyowa Kirin FY ending Dec 2018 results

Kyowa Kirin brought in ¥271.5B in revenue.

Revenue changed -23.2% from the prior year.

What changed from last year

FY ending Dec 2017 → FY ending Dec 2018

Revenue
-23.2%¥353.4B → ¥271.5B
Net income attributable to owners
+26.8%¥42.9B → ¥54.4B
Operating cash flow
-13.4%¥64.9B → ¥56.2B

Where the money goes

FY ending Dec 2017 → FY ending Dec 2018

※ Cost of revenue is not disclosed; expenses are combined

※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains

Where ¥100 of sales goes

Operating income is not available as a machine-readable numeric value for this company. See the income statement table in its filing.

Sources

Show source documents (3)

  • EDINET (FSA Japan)

    有価証券報告書－第100期(2022/01/01－2022/12/31)

    ID S100QCX22023-03-09Open

  • EDINET (FSA Japan)

    有価証券報告書－第99期(令和3年1月1日－令和3年12月31日)

    ID S100NMKA2022-03-08Open

  • EDINET (FSA Japan)

    有価証券報告書－第98期(令和2年1月1日－令和2年12月31日)

    ID S100KWXR2021-03-09Open

Extracted from XBRL: 18 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image